atorvastatin has been researched along with lysophosphatidylcholines in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choy, PC; Dembinski, T; Hatch, G; Kroeger, EA; McMaster, J; Mymin, D; Zhu, Q | 1 |
| Ameliushkina, VA; Kaminnyĭ, AI; Korotaeva, AA; Kucharchuk, VV; Naumov, VG; Pirkova, AA; Prokazova, NV; Samoĭlova, EV; Titov, VN | 1 |
1 trial(s) available for atorvastatin and lysophosphatidylcholines
| Article | Year |
|---|---|
[Effect of atorvastatin therapy on the level of secretory phospholipase A2 group IIA and on the modification of low density lipoproteins in patients with ischemic heart disease].
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Cholesterol; Group II Phospholipases A2; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lecithins; Lipoproteins, LDL; Lysophosphatidylcholines; Male; Middle Aged; Myocardial Ischemia; Pyrroles; Treatment Outcome; Triglycerides | 2007 |
1 other study(ies) available for atorvastatin and lysophosphatidylcholines
| Article | Year |
|---|---|
Effects of atorvastatin treatment on the oxidatively modified low density lipoprotein in hyperlipidemic patients.
Topics: Adult; Anticholesteremic Agents; Atorvastatin; Combined Modality Therapy; Diet Therapy; Endothelium, Vascular; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Lysophosphatidylcholines; Muscle, Smooth, Vascular; Oxidation-Reduction; Phospholipids; Pyrroles | 2000 |